Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice.

MLA

Bekaii-Saab, Tanios, et al. “Third- or Later-Line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice.” Clinical Colorectal Cancer, vol. 18, no. 1, Mar. 2019, pp. e117–29. EBSCOhost, https://doi.org/10.1016/j.clcc.2018.11.002.

APA

Bekaii-Saab, T., Kim, R., Tae Won Kim, O’Connor, J. M., Strickler, J. H., Malka, D., Sartore-Bianchi, A., Feng Bi, Kensei Yamaguchi, Takayuki Yoshino, Prager, G. W., Kim, T. W., Bi, F., Yamaguchi, K., & Yoshino, T. (2019). Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice. Clinical Colorectal Cancer, 18(1), e117–e129. https://doi.org/10.1016/j.clcc.2018.11.002

Chicago

Bekaii-Saab, Tanios, Richard Kim, Tae Won Kim, Juan Manuel O’Connor, John H. Strickler, David Malka, Andrea Sartore-Bianchi, et al. 2019. “Third- or Later-Line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice.” Clinical Colorectal Cancer 18 (1): e117–29. doi:10.1016/j.clcc.2018.11.002.